Impact Capital Partners LLC bought a new stake in Chemed Co. (NYSE:CHE - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 743 shares of the company's stock, valued at approximately $394,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. UMB Bank n.a. lifted its stake in Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after buying an additional 39 shares in the last quarter. Trust Co. of Vermont acquired a new position in Chemed in the 4th quarter valued at $34,000. Tortoise Investment Management LLC raised its holdings in Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock valued at $41,000 after acquiring an additional 34 shares during the last quarter. SRS Capital Advisors Inc. raised its holdings in Chemed by 39.2% in the 4th quarter. SRS Capital Advisors Inc. now owns 135 shares of the company's stock valued at $72,000 after acquiring an additional 38 shares during the last quarter. Finally, Allworth Financial LP raised its holdings in Chemed by 2,057.1% in the 4th quarter. Allworth Financial LP now owns 151 shares of the company's stock valued at $83,000 after acquiring an additional 144 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.
Insider Transactions at Chemed
In related news, VP Brian C. Judkins purchased 145 shares of the stock in a transaction that occurred on Monday, December 30th. The stock was purchased at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the acquisition, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the sale, the chief executive officer now owns 102,679 shares of the company's stock, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 3.32% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts have weighed in on the company. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th. Royal Bank of Canada upped their price objective on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a report on Friday.
Read Our Latest Report on CHE
Chemed Stock Down 0.4 %
Shares of CHE stock traded down $2.45 on Tuesday, reaching $605.62. 96,441 shares of the stock were exchanged, compared to its average volume of 100,983. The stock has a market cap of $8.86 billion, a P/E ratio of 30.60, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. The firm has a 50 day moving average of $561.91 and a two-hundred day moving average of $564.94. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $653.75.
Chemed Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a dividend of $0.50 per share. The ex-dividend date was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. Chemed's payout ratio is 10.05%.
Chemed Profile
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
See Also

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.